Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its effects on appetite, body weight, and metabolic function. Researchers are interested in this peptide because it may help regulate food intake, improve glucose control, and support significant changes in body composition.
Scientific Information
- Full Name: Tirzepatide
- Molecular Weight: ~4,814 Daltons
- Structure: Tirzepatide is a synthetic peptide designed to activate both GIP and GLP-1 receptors, giving it a broader incretin-based mechanism than single-pathway peptides.
Research & Potential Benefits
-
Appetite & Weight Management Research:
Studies suggest tirzepatide may significantly reduce body weight by influencing appetite and energy intake. (Reference 1, 2) -
Body Composition Changes:
Research has shown tirzepatide may reduce fat mass while supporting broader improvements in body composition. (Reference 2, 3) -
Metabolic Function:
Tirzepatide has been studied for improving glycemic control and other metabolic markers in adults with obesity or type 2 diabetes. (Reference 1, 4) -
Weight Maintenance Research:
Continued-use studies suggest that maintaining treatment may help preserve weight loss over time. (Reference 3, 4)
References
- Jastreboff, A.M. et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” New England Journal of Medicine.
- Look, M. et al. “Body composition changes during weight reduction with tirzepatide in SURMOUNT-1.” Obesity.
- Aronne, L.J. et al. “Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity or Overweight.” JAMA.
- Hamza, M. et al. “Tirzepatide for overweight and obesity management.” Expert Opinion on Pharmacotherapy.
Disclaimer
For Research Use Only. Not for human consumption.
